New hope for pancreatic cancer: drug combo trial launches
NCT ID NCT06584227
First seen Jan 06, 2026 · Last updated May 10, 2026 · Updated 13 times
Summary
This study tests a combination of two drugs (adebrelimab and chidamide) plus standard chemotherapy for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this mix can slow tumor growth and help patients live longer. About 45 adults who have not had prior treatment for their advanced cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jinling Hospital, Nanjing Medical University
RECRUITINGNanjing, Jiangsu, 210000, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.